Show simple item record

dc.creatorBoza W,Camilo
dc.creatorMertens M,Renato
dc.creatorValdés E,Francisco
dc.creatorKramer Sch,Albrecht
dc.creatorMariné M,Leopoldo
dc.creatorVergara G,Jeanette
dc.date2001-04-01
dc.date.accessioned2019-11-14T12:55:06Z
dc.date.available2019-11-14T12:55:06Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872001000400011
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/116952
dc.descriptionThe treatment of superior vena cava syndrome is usually oriented to the underlying cause, that can be too slow in emergency cases. We report a 49 years old woman with a multiple myeloma that was admitted due to a superior vena cava syndrome caused by a central venous catheter used for chemotherapy for 20 weeks. She was successfully treated with thrombolysis, angioplasty and stent placement. The patient died 7 months later due to the underlying disease. Long term catheters are the responsible for 20 to 30% of superior vena cava syndromes. Endovascular treatment of the syndrome is successful in 60 to 100% of cases with a symptomatic relapse in 4 to 45% of patients. (Rev Méd Chile 2001; 129: 421-6)
dc.formattext/html
dc.languagees
dc.publisherSociedad Médica de Santiago
dc.relation10.4067/S0034-98872001000400011
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceRevista médica de Chile v.129 n.4 2001
dc.subjectCatheterization, central venous
dc.subjectCatheterization, peripheral
dc.subjectSuperior vena cava syndrome
dc.titleTerapia endovascular en el sindrome de vena cava superior: caso clínico


This item appears in the following Collection(s)

Show simple item record